We are live on ! Find out more
APVO icon

Aptevo Therapeutics

hedge funds and large institutions have $37.4M invested in Aptevo Therapeutics in 2018 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more capital invested

Capital invested by funds: $25.2M → $37.4M (+$12.2M)

Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Dimensional Fund Advisors
1
Dimensional Fund Advisors
Texas
$6.75M
Renaissance Technologies
2
Renaissance Technologies
New York
$5.74M
Vanguard Group
3
Vanguard Group
Pennsylvania
$3.66M
SC
4
Sessa Capital
New York
$2.59M
PWAM
5
Park West Asset Management
California
$2.5M
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$1.83M
BlackRock
7
BlackRock
New York
$1.75M
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$1.58M
JP Morgan Chase
9
JP Morgan Chase
New York
$1.45M
HS
10
HighVista Strategies
Massachusetts
$981K
OAM
11
Oxford Asset Management
United Kingdom
$874K
SIM
12
Spark Investment Management
New York
$676K
CL
13
CSS LLC
Illinois
$592K
AIM
14
Alambic Investment Management
California
$581K
EI
15
EAM Investors
California
$552K
Geode Capital Management
16
Geode Capital Management
Massachusetts
$552K
BCM
17
Bridgeway Capital Management
Texas
$469K
Macquarie Group
18
Macquarie Group
Australia
$386K
Man Group
19
Man Group
United Kingdom
$380K
Deutsche Bank
20
Deutsche Bank
Germany
$363K
Northern Trust
21
Northern Trust
Illinois
$352K
Millennium Management
22
Millennium Management
New York
$318K
QI
23
QS Investors
New York
$315K
ACA
24
Atlas Capital Advisors
Wyoming
$232K
UBS Group
25
UBS Group
Switzerland
$189K